Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

Item

http://www.wikidata.org/entity/Q34172879

Q34172879

about

Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review Systemic anti-tumour effects of local thermally sensitive liposome therapy Novel therapy for locally advanced triple-negative breast cancer.Biological lipid membranes for on-demand, wireless drug delivery from thin, bioresorbable electronic implants Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice.The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With in vivo Two-Photon Microscopy.Realistic biological approaches for improving thermoradiotherapy.Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer.Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients.Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit Vx2 tumours.Target visualisation and microwave hyperthermia monitoring using nanoparticle-enhanced transmission ultrasound (NETUS).Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.Transport of drugs from blood vessels to tumour tissue.Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating.A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma.Nanoparticles in the clinic.

P2860

Q26753882-6FE9B65D-1AEE-4F89-B9D6-6F4D668DFCD9 Q35631592-AA9D4B41-E466-44FD-9200-5A58F9D0948D Q36094096-E95EBE45-5C40-4C33-B38A-15B75ED34D44 Q36884551-EE121A44-AA51-4871-964A-08F80E8A6205 Q37602839-527CF579-A804-4036-A80E-6CA819CE2A97 Q37745399-87B8C490-A6BB-415C-A483-5D19731775A1 Q38640494-7D4B780F-8C52-4BAC-A5CA-95B5D523C102 Q38648236-90C529B2-2D45-4E39-BD9D-C6323D345533 Q38813394-885429E6-0927-428B-8231-1310216C85A8 Q38822174-BB7DBA2C-1D3E-4177-AA89-B987926F26F6 Q41591819-9E7251BD-E00F-4F04-B0F8-A53F0F583265 Q47417013-92F878AC-D955-4BAD-ADA6-E48F3AE933E9 Q48724706-F4645EC9-4062-46B0-A2E4-1F047B2FBF64 Q50072050-11C834E6-EF79-449A-8BE1-1C7DFBEF9966 Q50082408-5E558266-5117-4E8B-A728-87355420DCD3 Q53542195-3DF53680-55D0-48D6-8BB5-75CEDB2B4AB7 Q53803184-0415EE1B-0EDC-4D65-899F-9F74563D8681 Q55003489-90785FB7-91FA-406D-8C22-8247BA27C41F

P2860

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

Item

http://www.wikidata.org/entity/Q34172879

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@ast

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@en

Two phase I dose-escalation/ph ...... perature liposomal doxorubicin

@nl

type

Item

label

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@ast

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@en

Two phase I dose-escalation/ph ...... perature liposomal doxorubicin

@nl

prefLabel

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@ast

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@en

Two phase I dose-escalation/ph ...... perature liposomal doxorubicin

@nl

P1476

Two phase I dose-escalation/ph ...... onally recurrent breast cancer

@en

P2093

Alina Boico

http://www.w3.org/2001/XMLSchema#string

Brigid O'Connor

http://www.w3.org/2001/XMLSchema#string

Chris Diederich

http://www.w3.org/2001/XMLSchema#string

David Needham

http://www.w3.org/2001/XMLSchema#string

Hope Rugo

http://www.w3.org/2001/XMLSchema#string

I-Chow Hsu

http://www.w3.org/2001/XMLSchema#string

Kimberly L Blackwell

http://www.w3.org/2001/XMLSchema#string

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Mary-Keara Boss

http://www.w3.org/2001/XMLSchema#string

Nicholas Borys

http://www.w3.org/2001/XMLSchema#string

P2860

Thermal characteristics of thermobrachytherapy surface applicators for treating chest wall recurrence

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer

Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.

A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.

Locoregionally recurrent breast cancer: incidence, risk factors and survival.

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition.

P304

285-294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02656736.2014.936049

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Franco Muggia

Paul R. Stauffer

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264987747

http://www.w3.org/2001/XMLSchema#string

P698

25144817

http://www.w3.org/2001/XMLSchema#string

P932

4162656

http://www.w3.org/2001/XMLSchema#string

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

about

P2860

P2860

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932